Understanding decisions about multi-cancer early detection tests
This study looks at how people decide about multi-cancer early detection (MCED) blood tests, which are designed to screen for multiple types of cancer at once. You would not receive the test, but you would answer questions about your preferences and opinions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 74 years old.
- You speak English or Spanish.
- You have never been diagnosed with cancer (except for non-melanoma skin cancer).
- You have never taken a multi-cancer early detection (MCED) test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether a blood test can detect early signs of multiple cancers in people who feel well. It may help find cancer earlier, when treatment is more likely to work.
This trial tests a new screening tool that helps doctors find cancer. It involves completing medical exams and questionnaires. The study is for people who have not had cancer in the last 5 years.
This study tests a decision aid to help women at high risk for breast cancer decide whether to get a screening MRI. It is designed for Black and Latina women who have had a normal mammogram in the past year.
This study tests a blood test that looks for signs of cancer early in people without symptoms. It aims to see how well the test works in real-world settings.
This study will collect blood samples from people who have had or are scheduled to have a multi-cancer detection test. Researchers want to learn more about how well these tests work and how the results affect follow-up care.
This study is testing a new blood test that may help find cancer early. You will give blood samples over a year, and researchers will check them for signs of cancer.
Hear when a new Early Detection of Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.